Skip to main content
Clinical Trials/NCT03403985
NCT03403985
Unknown
Not Applicable

Long-term Evaluation of Direct Pulp Capping Using Either Mineral Trioxid Aggregate or Calcium Hydroxide in Permanent Mature Teeth: A Randomized Controlled Trial

Jordan University of Science and Technology1 site in 1 country80 target enrollmentJune 1, 2017

Overview

Phase
Not Applicable
Intervention
Calcium Hydroxide (Ca(OH)2)
Conditions
Dental Pulp Capping
Sponsor
Jordan University of Science and Technology
Enrollment
80
Locations
1
Primary Endpoint
clinical vital pulp therapy success
Last Updated
6 years ago

Overview

Brief Summary

Calcium hydroxide and mineral trioxide aggregate have been used in vital pulp therapy with variable outcomes recorded by different study. They will be compared when used for direct pulp capping in cariously exposed mature permanent teeth.

Detailed Description

Vital pulp therapy has the benefit of providing patients with a conservative treatment option with relatively low cost when compared to conventional root canal treatment and spares them possible post-treatment consequences that might occur. Vital pulp treatment in trauma cases is associated with high success rate but controversy still exists regarding vital pulp treatment in carious-exposed pulp. The purpose of this study is to evaluate the success rate of direct pulp capping performed with MTA-Angelus® or calcium hydroxide in mechanical-exposed or carious-exposed mature permanent human teeth. Patients included in this study will be recruited from routine dental patients attending conservative clinics in JUST Dental Teaching Centre. Adult patients scheduled for routine conservative treatment involving caries removal and restoration with mechanical or carious pulp exposure will be invited to participate in this study. A total of 80 carious human teeth with carious pulp exposure will be included in this randomized clinical study. Patients are among those scheduled for conservative dental treatment and end with pulp exposure. The patients and/or their parents will be asked to sign a consent form after receiving a detailed explanation about the study rationale, clinical procedures, and possible risks. The exposed teeth will be divided randomly into two experimental groups (n=40) according to the dressing materials; MTA-Angelus® or calcium hydroxide, then teeth will be restored with permanent filling. Teeth will be reviewed recording any signs and symptoms. Patients will be reviewed in 1 week, 3 months and yearly after. MTA-Angelus and calcium hydroxide are anticipated to be biocompatible and induce hard tissue barrier. This project will reveal if tested materials are presented with promising profile upon using as direct pulp capping dressing in mechanical and carious-exposed pulp.

Registry
clinicaltrials.gov
Start Date
June 1, 2017
End Date
June 2022
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • carious teeth that had no previous root canal treatment
  • Pulpal diagnosis of normal or reversible pulpitis

Exclusion Criteria

  • History of irreversible pulpal pain
  • Immature teeth
  • Non restorable teeth
  • Teeth with active periodontal disease
  • History of any systemic disease
  • Concurrent medication with systemic steroids, antibiotics, analgesics, immunomodulatory drugs or cytotoxics

Arms & Interventions

calcium hydroxide direct pulp capping

calcium hydroxide (Ca(OH)2 direct pulp capping will be performed in this group

Intervention: Calcium Hydroxide (Ca(OH)2)

MTA direct pulp capping

Mineral Trioxide Aggregate (MTA) direct pulp capping will be performed in this group

Intervention: Mineral Trioxide Aggregate

Outcomes

Primary Outcomes

clinical vital pulp therapy success

Time Frame: from date of randomization until failure reported for up to 100 months

Treatment was considered successful based on the absence of symptoms and signs Treatment was considered successful based on absence of symptoms and signs

Secondary Outcomes

  • Radiographic success(from date of randomization until failure reported for up to 100 months)

Study Sites (1)

Loading locations...

Similar Trials